Erratum: Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.

Leung J, Nguyen-Traxler A, Lee EM, et al. Erratum: Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.. Allergy and asthma proceedings. 2013;34(1):107.

Publisher's Version

Last updated on 01/17/2023
PubMed

Walter W. Chan, MD, MPH, FACG, AGAF, FAFS

Associate Professor of Medicine, Harvard Medical School

Director, Center for Gastrointestinal Motility, Brigham and Women's Hospital

Director, Clinical Research Education, Division of Gastroenterology, Hepatology and Endoscopy

Erratum: Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis.

Walter W. Chan, MD, MPH

Navigation

Contact Information